Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

U. F. Wagner,Christian Marth,Rémy Largillier,Janne Kærn,Chris L. Brown,Mason C. Heywood,Tony Bonaventura,Ignace Vergote,Maria Carmela Piccirillo,Rolando Fossati,Val Gebski,Eric Pujade Lauraine

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

2012

U. F. Wagner
Christian Marth
Rémy Largillier
Janne Kærn
Chris L. Brown
Mason C. Heywood
Tony Bonaventura
Ignace Vergote
Maria Carmela Piccirillo
Rolando Fossati
Val Gebski
Eric Pujade Lauraine

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

Keywords:

Ovarian cancer
Pegylated Liposomal Doxorubicin
Oncology
Carboplatin
Pathology
Doxorubicin
Medicine
Recurrent Ovarian Cancer
Gynecology
Paclitaxel
Internal medicine
overall survival
disease free survival
Surgery
platinum sensitive

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

125

Citations